. 2017 Jun;18(6):501–511. doi: 10.1631/jzus.B1500291

Table 2.

Effects of H. plicatum extract on biochemical parameters of liver and kidney tissues

Group	MDA (nmol/g)	CAT (kU/g)	GPx (U/g)	SOD (EU/mg)
Liver
I	47.72±1.69^b	257.56±24.16^ab	10.26±0.88^bc	11.57±0.68^a
II	45.94±1.36^b	262.63±23.07^a	16.98±1.10^a	11.87±0.73^a
III	51.27±2.00^b	186.79±32.62^bc	11.27±0.55^bc	11.64±0.57^a
IV	64.24±6.64^a	91.48±4.80^d	9.36±0.13^bc	5.51±0.44^c
V	49.68±2.06^b	232.30±31.57^abc	12.48±0.78^b	8.08±0.43^b
VI	51.99±0.73^b	177.43±12.74^c	9.62±0.54^bc	5.91±0.36^c

P	^**	^***	^***	^***

Kidney
I	55.46±0.62^c	255.29±50.96^b	16.62±2.73^a	12.28±0.88^a
II	52.70±3.00^c	379.22±30.31^a	19.83±1.73^a	14.76±1.53^a
III	61.90±3.91^bc	357.33±41.98^a	17.61±2.49^a	14.54±0.95^a
IV	108.43±5.88^a	64.59±13.31^e	6.54±0.11^c	7.46±0.56^b
V	55.67±3.09^c	223.08±11.35^b	7.42±0.25^c	12.61±0.29^a
VI	73.30±5.77^b	127.56±20.56^cde	7.05±0.08^c	7.77±0.64^b

P	^***	^***	^***	^***

Group I: control group; Group II: HPE1-administered group; Group III: HPE2-administered group; Group IV: gentamicin-administered group; Group V: gentamicin-plus-HPE1-treated group; Group VI: gentamicin-plus-HPE2-treated group. EU: enzyme unit. Data are expressed as mean±SEM (n=6). Values with different superscripts within one column differ significantly.

^**

P<0.01,

^***

P<0.001